📖 Read more: Psychedelics & Therapy: The New Scientific Approach
What Is Micro-Dosing
Micro-dosing involves taking 1/10 to 1/20 of a normal dose of psychedelic substances — typically psilocybin or LSD — every 3-4 days. The dose is so small it doesn't produce psychedelic effects (hallucinations, altered perception). The Fadiman protocol (2011) is the most well-known.
What Users Report
What the Research Says
Polito & Stevenson (2019) conducted one of the first systematic studies of microdosing. They found reductions in depression and absent-mindedness, but emphasize that without a control group (placebo), results must be interpreted with caution. DOI: 10.1371/journal.pone.0211023
📖 Read more: Gratitude: How It Literally Changes Your Brain
Anderson et al. (2019) found that microdosers report higher creativity, openness, and lower stress — but also higher neuroticism, suggesting the picture is complex. DOI: 10.1007/s00213-018-5106-2
📖 Read more: PTSD: How Trauma Changes the Brain
The Placebo Question
The most rigorous study to date cast a shadow over the enthusiasm:
Szigeti et al. (2021) conducted a groundbreaking self-blinding study where participants didn't know if they were taking a real dose or placebo. Result: no significant difference between the two groups. Both improved — suggesting a strong placebo effect. DOI: 10.7554/eLife.62878
📖 Read more: Sleep & Brain: 7 Secrets for Deeper Rest
Risks & Legal Status
⚠️ Legal Status
In most countries, psychedelics are illegal. Possession and use carry criminal penalties. Research is conducted under strict clinical trial licenses.
⚠️ Medical Risks
Unregulated doses, drug interactions (especially with SSRIs), risk of worsening symptoms in individuals predisposed to psychosis, and no quality control on the black market.
📖 Read more: Bipolar Disorder: What You Need to Know
🔬 Science Hasn't Finished Yet
We need more randomized clinical trials to separate the real effect from expectation. Until then, science tells us: "we don't know yet".